For the year ending 2025-12-31, RCKTW has $330,449K in assets. $53,228K in debts. $77,558K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 77,558 | |||
| Investments | 111,371 | |||
| Prepaid expenses and other current assets | 3,805 | |||
| Total current assets | 192,734 | |||
| Property and equipment, gross | 57,293 | |||
| Less accumulated depreciation and amortization | 29,123 | |||
| Property and equipment, net | 28,170 | |||
| Goodwill | 39,154 | |||
| Intangible assets | 25,150 | |||
| Restricted cash | 1,340 | |||
| Deposits | 482 | |||
| Operating lease right-of-use assets, net | 3,210 | |||
| Finance lease right-of-use asset, net | 40,209 | |||
| Total assets | 330,449 | |||
| Accounts payable and accrued expenses | 27,291 | |||
| Operating lease liabilities, current | 1,003 | |||
| Finance lease liability, current | 1,912 | |||
| Total current liabilities | 30,206 | |||
| Operating lease liabilities, non-current | 2,600 | |||
| Finance lease liability, non-current | 19,362 | |||
| Other liabilities | 1,060 | |||
| Total liabilities | 53,228 | |||
| Common stock, 0.01 par value, 180,000,000 shares authorized 108,319,783 and 106,453,818 shares issued and outstanding as of december 31, 2025, and december 31, 2024, respectively | 1,083 | |||
| Additional paid-in capital | 1,717,408 | |||
| Accumulated other comprehensive (loss) income | -31 | |||
| Accumulated deficit | -1,441,239 | |||
| Total stockholders' equity | 277,221 | |||
| Total liabilities and stockholders' equity | 330,449 | |||
ROCKET PHARMACEUTICALS, INC. (RCKTW)
ROCKET PHARMACEUTICALS, INC. (RCKTW)